To evaluate immediate implant placement feasibility and esthetic outcomes in severely damaged sockets that received simultaneously bone reconstruction (cortical bone shield) and implant placement versus intact sockets that needed no reconstruction and had immediate implant placement.
The present clinical trial aims at demonstrating facial bone regeneration on sites that presented large buccal bone dehiscences \& vertical bone loss and evaluate the feasibility of performing simultaneous bone augmentation and implant placement, comparing the outcomes with sites that had intact sockets that did not require reconstruction. A secondary objective was to evaluate pink esthetics and marginal bone levels at final follow-up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
50
autogenous bone reconstruction of damaged socket \& simultaneous implant placement
FV, DDS,Corp
San Gabriel, California, United States
Evaluate implant placement feasibility & success rate at 12 months
evaluate implant success following Karoussis et al. success criteria
Time frame: 12 months
Number of individuals with low pink esthetic outcomes as assessed by pink esthetic scores (PES)
pink esthetics scores (PES) as proposed by Belser et al. Values 0-10 were 10 is the best esthetic outcome.
Time frame: 12 months
Implant transparency: clinical presence or absence
Visual evaluation of facial mucosal implant transparency at 12 months: positive or negative
Time frame: 12 months
Number of participants with >0.2mm of marginal bone levels
evaluate radiographic marginal bone levels at 12 months with \>0.2mm of bone loss
Time frame: 12 months
Band of keratinized tissue: clinical presence or absence
evaluate the presence of facial keratinized tissue on the implant sites \>2 or \<2mm
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.